Cannara Biotech Inc. (C:LOVE*CA)

Business Focus: Alternative Medicine

Oct 10, 2019 07:30 am ET
Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce
VANCOUVER, Oct. 10, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation and sale of premium cannabis and cannabis-infused products, announced it has secured a first mortgage against its Farnham Facility in the value of $6 million with the Canadian Imperial Bank of Commerce. These funds will reduce the existing vendor take-back mortgage, thereby significantly reducing debt service costs.
Oct 10, 2019 07:30 am ET
Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce
VANCOUVER, Oct. 10, 2019 /PRNewswire/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation and sale of premium cannabis and cannabis-infused products, announced it has secured a first mortgage against its Farnham Facility in the value of $6 million with the Canadian Imperial Bank of Commerce. These funds will reduce the existing vendor take-back mortgage, thereby significantly reducing debt service costs....
Sep 12, 2019 01:30 pm ET
IIROC Trade Resumption - LOVE
VANCOUVER, Sept. 12, 2019 /CNW/ - Trading resumes in:
Sep 12, 2019 01:15 pm ET
Cannara Biotech Submits Site Evidence Package to Health Canada for its Quebec Facility
VANCOUVER, Sept. 12, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation and sale of  premium cannabis and cannabis-infused products, announced it has submitted to Health Canada its site evidence package for Phase One of the Company's cultivation and processing facility in Farnham, Quebec. The submission is the final step required to obtain a license to cultivate and process cannabis at the facility.
Sep 12, 2019 01:15 pm ET
Cannara Biotech Submits Site Evidence Package to Health Canada for its Quebec Facility
VANCOUVER, Sept. 12, 2019 /PRNewswire/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation and sale of  premium cannabis and cannabis-infused products, announced it has submitted to Health Canada its site evidence package for Phase One of the Company's cultivation and processing facility in Farnham, Quebec. The submission is the final step required to obtain a license to cultivate and process cannabis at the facility....
Sep 12, 2019 12:59 pm ET
IIROC Trading Halt - LOVE
VANCOUVER, Sept. 12, 2019 /CNW/ - The following issues have been halted by IIROC:
Aug 15, 2019 04:34 pm ET
Cannara Announces Appointment of New Chief Operating Officer
VANCOUVER, Aug. 15, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried premium cannabis and cannabis-infused products, today announced the appointment of Barry Laxer as Cannara's new Chief Operating Officer, effective August 14, 2019. Barry is a successful business leader that brings over 25 years of experience of leading large-scale operations both domestically and internationally.
Aug 15, 2019 04:34 pm ET
Cannara Announces Appointment of New Chief Operating Officer
VANCOUVER, Aug. 15, 2019 /PRNewswire/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried premium cannabis and cannabis-infused products, today announced the appointment of Barry Laxer as Cannara's new Chief Operating Officer, effective August 14, 2019. Barry is a successful business leader that brings over 25 years of experience of leading large-scale operations both domestically and internationally. ...
Aug 05, 2019 08:35 am ET
OTCQB Venture Company Investor Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations
Aug 05, 2019 08:35 am ET
OTCQB Venture Company Investor Presentations Now Available for On-Demand Viewing
NEW YORK, Aug. 5, 2019 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the August 1, 2019 OTCQB Venture Company Conference are now available for on-demand viewing at VirtualInvestorConferences.com....
Jul 31, 2019 08:35 am ET
Cannara Biotech to Webcast Live at VirtualInvestorConferences.com August 1
VANCOUVER, British Columbia, July 31, 2019 /PRNewswire/ -- Cannara Biotech (OTCQB:LOVFF) (CSE: LOVE), based in Montreal, Canada, is focused on the production and sale of premium cannabis and cannabis-infused products for the Canadian and international markets, today announced that Lennie Ryer, Cannara Biotech's Chief Financial Officer, will present live at VirtualInvestorConferences.com on August 1....
Jul 30, 2019 08:35 am ET
Cannara Biotech to Webcast Live at VirtualInvestorConferences.com August 1
VANCOUVER, British Columbia, July 30, 2019 /PRNewswire/ -- Cannara Biotech (OTCQB: LOVFF) (CSE: LOVE), based in Montreal, Canada, is focused on the production and sale of premium cannabis and cannabis-infused products for the Canadian and international markets, today announced that Lennie Ryer, Cannara Biotech's Chief Financial Officer, will present live at VirtualInvestorConferences.com on August 1....
Jul 30, 2019 08:35 am ET
Live OTCQB Venture Company Investor Conference August 1st
Company executives will share vision and answer audience questions at VirtualInvestorConferences.com
Jul 30, 2019 08:35 am ET
Live OTCQB Venture Company Investor Conference August 1st
NEW YORK, July 30, 2019 /PRNewswire/ -- Virtual Investor Conferences today announced the agenda for the upcoming Virtual lnvestor Conference, the leading proprietary investor conference series.  Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 9:15 AM ET, with the first live webcast at 9:30 AM ET, on Thursday, August 1st.  ...
Jul 25, 2019 07:30 am ET
Cannara Biotech Inc. Reports Q3 2019 Results
VANCOUVER, July 25, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB) (OTCQB: LOVFF), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried premium cannabis and cannabis-infused products, today announced financial results for the three month and nine month periods ended May 31, 2019.
Jul 25, 2019 07:30 am ET
Cannara Biotech Inc. Reports Q3 2019 Results
VANCOUVER, July 25, 2019 /PRNewswire/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB) (OTCQB: LOVFF), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried premium cannabis and cannabis-infused products, today announced financial results for the three month and nine month periods ended May 31, 2019....
Jul 12, 2019 07:30 am ET
Cannara Biotech Announces Non-Brokered Private Placement of 12,000,000 Common Shares
VANCOUVER, July 12, 2019 /CNW/ - Cannara Biotech Inc. (the "Corporation" or "Cannara") (CSE: LOVE) (FRA: 8CB) (OTCMKTS: LOVFF), an emerging vertically integrated cannabis company focused on cultivation, and cannabis-infused products, is pleased to announce that it has raised $2,160,000 by way of non-brokered private placement of common shares of the Corporation (each a "Common Share" and collectively, the "Common Shares") at a price of $0.18 per Common Share (the "Offering"). The net proceeds from the Offering shall be used for general corporate purposes including the ongoing build-out at Ca
Jul 12, 2019 07:30 am ET
Cannara Biotech Announces Non-Brokered Private Placement of 12,000,000 Common Shares
VANCOUVER, July 12, 2019 /PRNewswire/ - Cannara Biotech Inc. (the "Corporation" or "Cannara") (CSE: LOVE) (FRA: 8CB) (OTCMKTS: LOVFF), an emerging vertically integrated cannabis company focused on cultivation, and cannabis-infused products, is pleased to announce that it has raised $2,160,000 by way of non-brokered private placement of common shares of the Corporation (each a "Common Share" and collectively, the "Common Shares") at a price of $0.18 per Common Share (the "Offering"). The net proceeds from the Offering shall be used for general corporate purposes including the ongoing build-ou...
Jul 03, 2019 05:00 pm ET
Horizons ETFs Rebalances Marijuana-Focused ETFs
TORONTO, July 3, 2019 /CNW/ - Horizons ETFs Management (Canada) Inc. ("Horizons ETFs") has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF ("HMMJ":TSX), the Horizons US Marijuana Index ETF ("HMUS":NEO) and the Horizons Emerging Marijuana Growers Index ETF ("HMJR":NEO).
May 24, 2019 07:30 am ET
Cannara Biotech Appoints Dr. Sara May to its Board of Directors
VANCOUVER, May 24, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB) (OTCMKTS: CNBTF), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the appointment of Dr. Sara May, PhD. to the Company's Board of Directors, effective immediately. Dr. May is recognized as an expert in the medical cannabis sector and will bring  additional skill sets and help strengthen  the Company's Board.
May 24, 2019 07:30 am ET
Cannara Biotech Appoints Dr. Sara May to its Board of Directors
VANCOUVER, May 24, 2019 /PRNewswire/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB) (OTCMKTS: CNBTF), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the appointment of Dr. Sara May, PhD. to the Company's Board of Directors, effective immediately. Dr. May is recognized as an expert in the medical cannabis sector and will bring  additional skill sets and help strengthen  the Company's Board. ...
May 15, 2019 07:30 am ET
Cannara Biotech Commences Trading on the OTCQB Market in the United States
VANCOUVER, May 15, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB) (OTCQB: CNBTF), an emerging vertically integrated cannabis company focused on the cultivation and sale of cannabis and cannabis-infused products to the Canadian and international markets, today announced its common shares are listed for trading on the OTCQB® Venture Market under the  trading symbol "CNBTF".
May 15, 2019 07:30 am ET
Cannara Biotech Commences Trading on the OTCQB Market in the United States
VANCOUVER, May 15, 2019 /PRNewswire/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB) (OTCQB: CNBTF), an emerging vertically integrated cannabis company focused on the cultivation and sale of cannabis and cannabis-infused products to the Canadian and international markets, today announced its common shares are listed for trading on the OTCQB® Venture Market under the  trading symbol "CNBTF". ...
Apr 30, 2019 10:04 am ET
PSIQ ANNOUNCES RESELLER AGREEMENT WITH CANNARA BIOTECH SUBSIDIARY SHOPCBD.COM TO MARKET AND SELL ELITES CBD PRODUCT LINE WITHIN THE UNITED STATES
Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that its wholly owned subsidiary, Elite Products International, Inc. (“Elite”), has entered into a Reseller Agreement with Shopcbd.com, a subsidiary of Cannara Biotech, Inc. (CSE: "LOVE")...
Apr 29, 2019 07:30 am ET
Cannara Biotech Reports Q2 2019 Results
VANCOUVER, April 29, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried cannabis and cannabis-infused products to the Canadian and international markets, today announced financial results for the three month and six month periods ended February 28, 2019.
Apr 29, 2019 07:30 am ET
Cannara Biotech Reports Q2 2019 Results
VANCOUVER, April 29, 2019 /PRNewswire/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried cannabis and cannabis-infused products to the Canadian and international markets, today announced financial results for the three month and six month periods ended February 28, 2019....
Apr 08, 2019 07:30 am ET
Cannara Biotech Appoints Jack Kay as New Board Director
MONTREAL, April 8, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE FRA: 8CB), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the appointment of Jack Kay as a Director on Cannara's Board, effective immediately. Mr. Kay is generally recognized as one of Canada's leading pharmaceutical executives, having held senior positions in a number of firms, including CEO of Apotex.
Apr 08, 2019 07:30 am ET
Cannara Biotech Appoints Jack Kay as New Board Director
MONTREAL, April 8, 2019 /PRNewswire/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE FRA: 8CB), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the appointment of Jack Kay as a Director on Cannara's Board, effective immediately. Mr. Kay is generally recognized as one of Canada's leading pharmaceutical executives, having held senior positions in a number of firms, including CEO of Apotex....
Mar 28, 2019 10:00 am ET
The CBD Wave is Coming: How Companies are Prepared to Meet Market Demand
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot focusing on the rise of CBD within the overall cannabis market in the US and internationally, and how companies are preparing to deal with...
Mar 26, 2019 07:30 am ET
Cannara Biotech Subsidiary Global shopCBD.com Raises in Excess of $8.8 Million to Fuel U.S. Hemp-CBD E-Commerce Platform
MONTREAL, March 26, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced its subsidiary Global shopCBD.com Inc. ("shopCBD.com") has closed private rounds of financing for aggregate proceeds of $8,865,849.15 (the "Offering").  Cannara remains the majority shareholder of the U.S. based online e-commerce platform with an approximately 61% ownership position. 
Mar 26, 2019 07:30 am ET
Cannara Biotech Subsidiary Global shopCBD.com Raises in Excess of $8.8 Million to Fuel U.S. Hemp-CBD E-Commerce Platform
MONTREAL, March 26, 2019 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced its subsidiary Global shopCBD.com Inc. ("shopCBD.com") has closed private rounds of financing for aggregate proceeds of $8,865,849.15 (the "Offering").  Cannara remains the majority shareholder of the U.S. based online e-commerce platform with an approximately 61% ownership position.  ...
Mar 18, 2019 04:14 pm ET
Horizons ETFs Rebalances the Horizons Marijuana Life Sciences Index ETF
Quarterly rebalance includes a leading U.S.-based CBD producer
Mar 14, 2019 07:30 am ET
Cannara Biotech Announces Expansion of Phase 1 Build-Out and Board of Directors Update
MONTREAL, March 14, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB), a vertically integrated cannabis company in the making focused on cultivation and cannabis-infused products, today announced an expansion of the Phase 1 build-out of Cannara's facility from 130,000 to 170,000 square feet. As a result, the license application at Cannara's Farnham, in process with Health Canada, has been modified accordingly. The 40 000-square-foot expansion will provide more flexibility for cultivation and post-harvest operations. The timelines to complete Phase 1 constr
Mar 14, 2019 07:30 am ET
Cannara Biotech Announces Expansion of Phase 1 Build-Out and Board of Directors Update
MONTREAL, March 14, 2019 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB), a vertically integrated cannabis company in the making focused on cultivation and cannabis-infused products, today announced an expansion of the Phase 1 build-out of Cannara's facility from 130,000 to 170,000 square feet. As a result, the license application at Cannara's Farnham, in process with Health Canada, has been modified accordingly. The 40 000-square-foot expansion will provide more flexibility for cultivation and post-harvest operations. The timelines to complete Phase 1...
Feb 21, 2019 09:00 am ET
4 Companies Shaping The CBD-Infused Beverage Industry
With the global CBD movement supercharged by the 2018 U.S. Farm Bill, cannabis and beverage companies alike are officially beginning to launch CBD-infused beverage products in the U.S. market.The rollout of various CBD-infused beverages throughout...
Feb 11, 2019 06:30 am ET
Cannara Biotech Shares to Begin Trading on the Frankfurt Exchange
MONTRÉAL, Feb. 11, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (CSE: LOVE) (FRA: 8CB), a vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced its common shares are listed for trading on the Frankfurt Stock Exchange under the trading symbol "8CB". The Company's common shares continue to be listed on the Canadian Securities Exchange under the trading symbol "LOVE".  
Feb 11, 2019 06:30 am ET
Cannara Biotech Shares to Begin Trading on the Frankfurt Exchange
MONTRÉAL, Feb. 11, 2019 /PRNewswire/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (CSE: LOVE) (FRA: 8CB), a vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced its common shares are listed for trading on the Frankfurt Stock Exchange under the trading symbol "8CB". The Company's common shares continue to be listed on the Canadian Securities Exchange under the trading symbol "LOVE".  ...
Feb 07, 2019 06:30 am ET
Feb 07, 2019 06:30 am ET
Cannara Biotech Enters Cannabinoid-Infused Beverage Product Category
Partners with a Leading Quebec Microbrewery ...
Jan 29, 2019 06:30 am ET
Cannara Biotech Reports First Quarter Results
MONTRÉAL, Jan. 29, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE), is building a vertically integrated Cannabis company focused on cannabis derivative products, today announced its financial results for the three-month period ended November 30, 2018.
Jan 29, 2019 06:30 am ET
Cannara Biotech Reports First Quarter Results
MONTRÉAL, Jan. 29, 2019 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE), is building a vertically integrated Cannabis company focused on cannabis derivative products, today announced its financial results for the three-month period ended November 30, 2018. ...
Jan 24, 2019 06:30 am ET
Jan 24, 2019 06:30 am ET
Jan 15, 2019 09:10 am ET
CSE New Listing - Cannara Biotech Inc. Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com
Vancouver, British Columbia--(Newsfile Corp. - January 15, 2019) - Cannara Biotech (CSE:LOVE) is one of the latest new listings on the Canadian Securities Exchange. In June 2018, Cannara completed the acquisition of a 625,000 sq. ft. indoor facility in Farnham, Quebec, located 45 minutes from downtown Montreal.